Table 5.

Proportion of samples received by laboratory with sufficient volume for biomarker analysis by sample type.

Sample type	Stage 1 – asymptomatic analysable samples	Stage 2 – symptomatic analysable samples
Viral swab	11/11 (100.0%)	39/45 (86.7%) (30/33 (90.9%) adults) (0/3 (0.0%) younger children) (9/9 (100.0%) older children)
Saliva sponge	11/11 (100.0%)	33/45 (73.3%) (25/33 (75.8%) adults) (1/3 (33.3%) younger children) (8/9 (88.9%) older children)
Saliva drool	5/11 (45.4%) (5/7 (71.4%) adults) (0/3 (0.0%) older children) (0/1 (0.0%) younger children)	23/45 (51.1%) (16/33 (48.5%) adults) (0/3 (0.0%) younger children) (7/9 (77.8%) older children)